277 filings
Page 8 of 14
8-K
6km30s2kq6shr
18 Feb 15
EnteroMedics Reports Fourth Quarter 2014 Financial Results
12:00am
8-K
8s167n
9 Feb 15
Other Events
12:00am
8-K
5n1faskuumuv3dubymc3
14 Jan 15
EnteroMedics Announces FDA Approval of
12:00am
8-K
0tzccfv hrko
12 Nov 14
EnteroMedics Reports Third Quarter 2014 Financial Results
12:00am
8-K
ed1lypexuyjm0o y1
30 Oct 14
EnteroMedics Names Brad Hancock Chief Commercial Officer
12:00am
8-K
mmav8z2lj1a4lqb
1 Oct 14
Other Events
12:00am
8-K
gpa4flc9p82u
7 Aug 14
EnteroMedics Reports Second Quarter 2014 Financial Results
12:00am
8-K
wm2lwzc6ptqy2
25 Jun 14
Departure of Directors or Certain Officers
12:00am
8-K
t2sdshwtp26
20 Jun 14
Other Events
12:00am
8-K
5rxv iovrmabyg
18 Jun 14
Other Events
12:00am
8-K
rs6t6 o1dt8y
13 Jun 14
Entry into a Material Definitive Agreement
12:00am
8-K
1ylb e5k2wfi
13 May 14
Departure of Directors or Certain Officers
12:00am
8-K
tivj0wquam4rkh
8 May 14
Submission of Matters to a Vote of Security Holders
12:00am
8-K
2yrtj
30 Apr 14
EnteroMedics Reports First Quarter 2014 Financial Results
12:00am
8-K
7ng fkw0qtn8rhr557
10 Mar 14
Other Events
12:00am
8-K
xn5r 25pvttub
12 Feb 14
EnteroMedics Reports Fourth Quarter 2013 Financial Results
12:00am
8-K
mvhcm9hx 95285
3 Dec 13
EnteroMedics Announces 18 Month ReCharge Study Results
12:00am
8-K
jz47z
31 Oct 13
EnteroMedics Reports Third Quarter 2013 Financial Results
12:00am
8-K
b46 1sixtry7l26
24 Sep 13
EnteroMedics on Track for Approval Decision in First Half of 2014 Following Formal Response to Premarket Approval Application from FDA
12:00am
8-K
fkvbhpkkqu7apo
31 Jul 13
EnteroMedics Enters into $20.0 Million “At-the-Market” Equity Distribution Agreement with Canaccord Genuity
12:00am